ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "B cells"

  • 2019 American Transplant Congress

    Natural Anti-a Antibody Production In Mice Is Cd4 T Cell-independent

    I. Adam1, B. Motyka2, L. West3

    1Medical Microbiology & Immunology, University of Alberta, Edmonton, AB, Canada, 2Pediatrics, University of Alberta, Edmonton, AB, Canada, 3Pediatrics, Surgery, Immunology, Lab Medicine & Canadian Donation and Transplant Research Program, University of Alberta, Edmonton, AB, Canada

    *Purpose: ABO-incompatible organ transplants (ABOi-Tx) are at high risk of rapid rejection mediated by preformed ABO antibodies (Ab) except during infancy when they are absent.…
  • 2019 American Transplant Congress

    Association between CD19-Positive Rate and Antibody-Mediated Rejection Following Rituximab Administration in Kidney Transplant Recipients

    K. Nanmoku, T. Shinzato, T. Kubo, T. Shimizu, T. Yagisawa

    Surgical Branch, Institute of Kidney Diseases, Jichi Medical University Hospital, Shimotsuke, Japan

    *Purpose: Rituximab, which suppresses antibody production, is widely used for desensitization in ABO-incompatible and donor-specific antibody-positive kidney transplantation. However, data regarding the effects of individual…
  • 2019 American Transplant Congress

    Differential Expression of B Cell Activating Factor in Experimental Models of Acute and Chronic Active Antibody-Mediated Rejection

    S. Reese, N. Wilson, L. Ptak, R. Redfield, A. Djamali, S. E. Panzer

    University of Wisconsin Madison, Madison, WI

    *Purpose: The B cell survival cytokine, BAFF [B cell activating factor], promotes B cell maturation and is a marker of disease activity in a variety…
  • 2019 American Transplant Congress

    A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Lymphocyte Biology and Transplant Immunity

    L. Qiu1, J. Wang2, R. Fernandez3, X. Yeap1, S. Han1, F. Zheng1, C. Lin2, Z. J. Zhang1

    1Comprehensive Transplant Center, Department of Surgery, Northwestern University, Chicago, IL, 2Northwestern University, Chicago, IL, 3Department of Surgery, Northwestern University, Chicago, IL

    *Purpose: Spleen-derived lymphocytes and myeloid cell populations are critical to the development of organ transplant ischemia-reperfusion injury (IRI) and allograft rejection. In this study, we…
  • 2018 American Transplant Congress

    Prevention and Reversal of Diabetes through Restoration of B and T Cell Regulation and Immune Homeostasis

    K. Brayman,1 P. Chhabra,1 C. Wilson,2 A. Marshall,2 D. Moore.2

    1Surgery, University of Virginia, Charlottesville, VA; 2Pediatric Endocrinology, Vanderbilt University, Nashville, TN.

    Goal: To determine the mechanisms by which IgM restores immune homeostasis in new-onset diabetic NOD mice.Methods: 1) 5wks old non-obese diabetic (NOD) mice received mouse…
  • 2018 American Transplant Congress

    Role of B Cell Intrinsic NLRP3 in the Development of Chronic Rejection

    J. Nie,1 B. Ramaswami,2 X. Guo,3 R. Hoffman,2 G. Chalasani.3

    1Thoracic Surgery, Huazhong University of Science and Technology, Wuhan, Hubei, China; 2Surgery, Starzl Transplantation Institute, Pittsburgh, PA; 3Medicine, University of Pittsburgh, Pittsburgh, PA.

    Endogenous DAMPs elicited during transplantation are recognized via TLR-MyD88 and NLRP3-inflammosome pathways that are expressed in APCs including B cells. Here, we asked whether B…
  • 2018 American Transplant Congress

    Rituximab Induction to Prevent the Recurrence of PSC after Liver Transplantation-The Lessons Learned from ABO-Incompatible Living Donor Liver Transplantation-

    Y. Yamada,1 K. Hoshino,1 M. Shinoda,1 H. Obara,1 S. Uemoto,3 T. Kaido,3 H. Okajima,3 T. Yagi,4 T. Yoshizumi,5 Y. Inomata,6 T. Hibi,6 K. Kubota,7 T. Suzuki,8 Y. Kitagawa,1 H. Egawa,2 T. Kuroda.1

    1Surgery, Keio University School of Medicine, Tokyo, Japan; 2Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan; 3Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery, Kyoto University, Kyoto, Japan; 4Hepato-Biliary and Pancreatic Surgery, Okayama University, Okayama, Japan; 5Department of Surgery, Kyushu University, Fukuoka, Japan; 6Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan; 7Department of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan; 8Department of Pediatric Surgery, Fujita Health University School of Medicine, Aichi, Japan.

    Background: Multiple studies have failed to reveal an effective method for preventing the recurrence of primary sclerosing cholangitis (PSC) after liver transplantation (LTx). A national…
  • 2018 American Transplant Congress

    Dependency on CD4 T Cells, Foreign Protein, and CD22 for Generation of Antibody Response to Non-Self Blood Group A-Antigen in a Mouse Model

    I. Adam, B. Motyka, K. Tao, L. West.

    Alberta Transplant Institute, Canadian National Transplant Research Program, University of Alberta, Edmonton, AB, Canada.

    Background: ABO-incompatible heart transplantation (ABOi-HTx) is safe during infancy and allows increased donor access. B cell tolerance develops to donor A/B-antigens (Ag) after ABOi HTx…
  • 2018 American Transplant Congress

    Assessment of Immune Cell Profiles in HLA-Sensitized (HS) & Non-HS Patients (Pts) with End Stage Renal Disease (ESRD)

    S. Ge,1 M. Chu,1 E. Ortiz,1 A. Vo,2 D. Lovato,1 S. Jordan,2 M. Toyoda.1

    1Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA; 2Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background: Chronic inflammation is often seen in pts w/ ESRD. HLA-sensitization may create or be driven by the cytokines responsible for chronic inflammation. Here we…
  • 2018 American Transplant Congress

    Single Center Experience of HLA-Related Donor Specific Antibody in Living Donor Liver Transplantation

    H. Egawa,1 Y. Kotera,1 A. Ohmori,1 S. Yamashita,1 T. Kato,1 S. Nemoto,1 T. Ishizuka,2 M. Yamamoto.1

    1Surgery, Tokyo Women's Medical University, Tokyo, Japan; 2Clinical Laboratory, Tokyo Women's Medical University, Tokyo, Japan.

    Although impact of donor specific antibody in liver transplantation has been recognized, significance of desensitization is not established yet. Our aim is to share our…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 35
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences